Seth Lederman is Chief Executive Officer of Tonix Pharmaceuticals Holding Corp. (TNXP). The company reported total compensation of $3,168,830 for fiscal year 2025.
| Salary | $702,000 |
|---|---|
| Bonus | $596,700 |
| Stock awards | $0 |
| Option awards | $1,870,130 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $3,168,830 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Tonix Pharmaceuticals Holding Corp. filed March 30, 2026, accession 0001999371-26-007108.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Seth Lederman this page | Chief Executive Officer | $3,168,830 |
| Jessica Morris | Chief Operations Officer | $1,226,269 |
| Gregory Sullivan | Chief Medical Officer | $1,216,542 |
| Bradley Saenger | Chief Financial Officer | $1,143,513 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Tonix Pharmaceuticals Holding Corp. compensation brief.
Seth Lederman's compensation sits inside Tonix Pharmaceuticals Holding Corp.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.
The Tonix Pharmaceuticals Holding Corp. (TNXP) compensation brief